1.
Varshney N, Bhalla V, Gupta MK. Technical reasons for delay and denial of regulatory approval of Initial applications for (Abbreviated) New Drugs filed by Indian Companies by USFDA, 2005-2022. Int J Drug Reg Affairs [Internet]. 2024Mar.16 [cited 2024May19];12(1):54-0. Available from: https://ijdra.com/index.php/journal/article/view/653